Zhi Tong Cai Jing·2026-03-31 21:33Group 1 - The company's laboratory services achieved revenue of 8.1589 billion yuan, a year-on-year increase of 15.8% [1] - The gross margin for the year 2025 reached 44.7%, an increase of 0.3 percentage points compared to the previous year [1] - New orders in this segment grew by approximately 12% year-on-year [1] Group 2 - The company expanded multiple strategic partnerships in 2025, making significant progress in large collaborative projects [1] - The laboratory services revenue from biological sciences accounted for over 56% of total revenue [1] - As of December 31, 2025, the company employed 11,776 staff in laboratory services, including over 7,100 laboratory chemists, positioning itself as a leader in scale and experience globally [1] Group 3 - The company participated in 887 global innovative drug discovery projects during the reporting period [1] - The total revenue reported for the year ending December 31, 2025, was 14.095 billion yuan, reflecting a year-on-year growth of 14.8% [2] - The profit attributable to the parent company was 1.664 billion yuan, a decrease of 7.2% year-on-year, with basic earnings per share of 0.9443 yuan [2]